Alcohol and the clinical picture of gout

Alcohol and the clinical picture of gout

Tsel' issledovaniya. Izuchenie vliyaniya alkogolya na klinicheskie proyavleniya u bol'nykh podagricheskim artritom. Material i metody. V issledovanie vklyucheny 280 muzhchin, bol'nykh podagroy (kriterii S.L. Wallace). Dlya vyyavleniya skrytoy tyagi k alkogolyu ispol'zovalsya vopr...

Full description

Bibliographic Details
Main Authors:	V G Barskova, M S Eliseev, V A Nasonova, E L Nasonov, M S Yeliseyev, Ye L Nasonov
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2007-09-01
Series:	Современная ревматология
Online Access:	https://mrj.ima-press.net/mrj/article/view/122

Similar Items

Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout
by: V A Nasonova, et al.
Published: (2007-09-01)

Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout
by: V A Nasonova, et al.
Published: (2007-09-01)

Administration of chondroprotector piascledine in the treatment of secondary osteoarthritis in patients with gout
by: M. S. Eliseev, et al.
Published: (2016-05-01)

Cholesterol crystals in a gout tophus
by: M S Eliseev, et al.
Published: (2007-10-01)

Febuxostat is a novel drug in therapy for gout
by: V G Barskova, et al.
Published: (2011-04-01)

Canakinumab (an interleukin 1β inhibitor) is a breakthrough in the possibilities of anti-inflammatory therapy for gout
by: Maksim Sergeevich Eliseev, et al.
Published: (2013-11-01)

Use of citrate formulas in patients with gout and nephrolithiasis
by: F M Kudaeva, et al.
Published: (2007-09-01)

Gout, hyperuricemia and cardiovascular risk
by: A E Iljina, et al.
Published: (2009-02-01)

Carbohydrate metabolic disturbances in gout: detection rate and clinical featureS
by: Maksim Sergeevich Eliseev, et al.
Published: (2010-05-01)

MULTIMODALITY THERAPY FOR CHRONIC TOPHACEOUS GOUT
by: M S Eliseev, et al.
Published: (2008-12-01)

MULTIMODALITY THERAPY FOR CHRONIC TOPHACEOUS GOUT
by: M S Eliseev, et al.
Published: (2008-12-01)

Immunoresistance syndrome in gout patients and its influence on formation of clinical features of the disease
by: V G Barskova, et al.
Published: (2004-05-01)

A case of successful treatment for chronic tophaceous gout
by: E L Nasonov, et al.
Published: (2007-09-01)

Actovegin administration in patients with ulcerated gout tophuses
by: M S Eliseev, et al.
Published: (2005-10-01)

Comparison of speed of anti-inflammatory and analgesic effect appearance of nimesulid and diclofenac sodium tablets in gout arthritis: a randomized study
by: F. M. Kudaeva, et al.
Published: (2008-02-01)

Use of Blemaren citrate formula in gout patients with nephrolithiasis
by: M S Eliseev, et al.
Published: (2008-09-01)

Detection of sodium monourate crystals in biopsies of gastric mucosa in gout patients
by: V A Nasonova, et al.
Published: (2004-06-01)

EXPERIENCE OF ADMINISTRATION OF CANAKINUMAB, AN INTERLEUKIN 1β INHIBITOR, IN A PATIENT WITH CHRONIC TOPHACACEOUS GOUT
by: Maksim Sergeyevna Eliseev, et al.
Published: (2014-03-01)

Chronic gout: causes, clinical manifestations, treatment
by: Viktoriya Georgievna Barskova, et al.
Published: (2010-03-01)

SURVIVAL OF GOUT PATIENTS
by: M S Eliseev, et al.
Published: (2012-05-01)

Losartan therapy in gout patients
by: A. I. Ilyina, et al.
Published: (2008-04-01)

Main factors of gender dimorphism of gout (estrogens and diuretics vs alcohol and genetics)
by: Viktoriya Georgievna Barskova, et al.
Published: (2011-05-01)

Rational approaches to treating gout
by: V G Barskova, et al.
Published: (2008-03-01)

Rational approaches to treating gout
by: V G Barskova, et al.
Published: (2008-03-01)

CLINICAL FEATURES OF GOUT IN WOMEN: THE RESULTS OF A COMPARATIVE STUDY
by: M. S. Eliseev, et al.
Published: (2014-06-01)

Use of urisan in gout
by: A E Il'ina, et al.
Published: (2008-03-01)

Short-term glucocorticoid administration in patients with protracted and chronic gout arthritis. Part 2 — comparison of different medication forms efficacy
by: A A Fedorova, et al.
Published: (2008-10-01)

Short course of glucocorticoids in patients with protracted and chronic gout arthritis. Part I: predictors of therapy efficacy
by: A A Fedorova, et al.
Published: (2008-06-01)

Short term administration of glucocorticoids in patients with protracted and chronic gout arthritis. Part III – frequency of adverse events
by: A A Fedorova, et al.
Published: (2009-04-01)

Diagnosis of gout (a lecture)
by: V G Barskova
Published: (2012-08-01)

VALUE OF 24-HOUR BLOOD PRESSURE MONITORING IN THE DIAGNOSIS OF ARTERIAL HYPERTENSION IN PATIENTSWITH GOUT
by: E I Markelova, et al.
Published: (2010-02-01)

Time course of changes in the clinical manifestations of gout in men: Data of a 7-year retrospective follow-up
by: M S Eliseev, et al.
Published: (2015-05-01)

Rational approaches to diagnosing gout (according to the European Antirheumatic League Guidelines)
by: V G Barskova, et al.
Published: (2007-09-01)

Rational approaches to diagnosing gout (according to the European Antirheumatic League Guidelines)
by: V G Barskova, et al.
Published: (2007-09-01)

GOUT OUTCOMES. LITERATURE REVIEW. PART II. COMORBID DISEASES, RISK OF DEVELOPING CARDIOVASCULAR CATASTROPHES AND DEATH IN GOUT PATIENTS
by: Igor Sergeevich Denisov, et al.
Published: (2014-02-01)

GOUT OUTCOMES. A REVIEW OF LITERATURE. PART 1. GOUT: EPIDEMIOLOGY, RISK FACTORS, COURSE OF THE DISEASE WITH THE DEVELOPMENT OF CHRONIC TOPHUS FORM
by: Igor Sergeyevich Denisov, et al.
Published: (2013-12-01)

Therapy with canakinumab for gout
by: M. S. Eliseev, et al.
Published: (2019-04-01)

Tumor necrosis factor α (TNFα) role in the development of metabolic disturbances and atherosclerosis and TNFα antagonists influence on them in patients with rheumatic diseases
by: M S Eliseev, et al.
Published: (2009-04-01)

SIGNIFICANCE OF DIET AND DIETARY SUPPLEMENTS IN GOUT
by: A E Il'ina, et al.
Published: (2008-12-01)

ATYPICAL GOUT: SPINAL TOPHACEOUS INJURY
by: Maksim Sergeevich Eliseev, et al.
Published: (2013-12-01)

Cannot write session to /tmp/vufind_sessions/sess_megifu0vs5ldfm8v6ad7jsb544